Potential Impact of Prenatal Expanded Carrier Screening on the Incidence of Duchenne Muscular Dystrophy in Neonates.
Аннотация
INTRODUCTION
A hospital-based Duchenne muscular dystrophy (DMD) newborn screening (NBS) pilot that screened over 18,000 neonates between 2021 and 2024 did not identify a newborn with DMD (incidence 1/5,000 males). We hypothesized that prenatal expanded carrier screening (ECS) that included DMD might be impacting DMD incidence within our population. We therefore explored the extent of ECS and DMD carrier screening in the mothers of our DMD NBS newborns.
METHODS
A retrospective chart review was performed on mothers of newborns screened during the first week of each month from 1/2022 to 5/2024.
RESULTS
Of 2,613 mothers, 93.9% underwent ECS and 49.7% included DMD. Fifty percent of screened mothers underwent preconception screening. Screening panels with 11-50 genes were most commonly performed. ECS panels with ≥11 genes were most likely to include DMD. The number of mothers who underwent DMD carrier screening increased from 46.6% to 56.3% from the start to finish of the pilot.
CONCLUSION
With increasing uptake of prenatal maternal genetic screening, in conjunction with continuing expansion of gene lists for rare disorders, it is suggested that rare disorder incidence may decrease over time, either by avoiding an affected pregnancy with the help of artificial reproductive technology or pregnancy termination when prenatal diagnosis is initiated by ECS.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.